CYCLODX
Google image searchProduct monograph
Active ingredient
fludeoxyglucose 18f, 7.4 GBQ/ML
DIN: 02462958
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: CIUSS DE L'ESTRIE - CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE
Date: 04-FEB-2020
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09I — TUMOUR DETECTION (ATC, ATC/DDD)
- V09IX — Other diagnostic radiopharmaceuticals for tumour detection (ATC, ATC/DDD)
- V09IX04 — FLUDEOXYGLUCOSE (18F) (ATC/DDD)
